1. Home
  2. COCP vs NEHC Comparison

COCP vs NEHC Comparison

Compare COCP & NEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • NEHC
  • Stock Information
  • Founded
  • COCP 2006
  • NEHC 2023
  • Country
  • COCP United States
  • NEHC United States
  • Employees
  • COCP N/A
  • NEHC N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • NEHC
  • Sector
  • COCP Health Care
  • NEHC
  • Exchange
  • COCP Nasdaq
  • NEHC NYSE
  • Market Cap
  • COCP 15.3M
  • NEHC 12.6M
  • IPO Year
  • COCP N/A
  • NEHC N/A
  • Fundamental
  • Price
  • COCP $1.52
  • NEHC $0.78
  • Analyst Decision
  • COCP Strong Buy
  • NEHC
  • Analyst Count
  • COCP 1
  • NEHC 0
  • Target Price
  • COCP $7.00
  • NEHC N/A
  • AVG Volume (30 Days)
  • COCP 12.6K
  • NEHC 191.5K
  • Earning Date
  • COCP 05-20-2025
  • NEHC 01-01-0001
  • Dividend Yield
  • COCP N/A
  • NEHC N/A
  • EPS Growth
  • COCP N/A
  • NEHC N/A
  • EPS
  • COCP N/A
  • NEHC N/A
  • Revenue
  • COCP N/A
  • NEHC $532,780.00
  • Revenue This Year
  • COCP N/A
  • NEHC N/A
  • Revenue Next Year
  • COCP N/A
  • NEHC N/A
  • P/E Ratio
  • COCP N/A
  • NEHC N/A
  • Revenue Growth
  • COCP N/A
  • NEHC N/A
  • 52 Week Low
  • COCP $1.12
  • NEHC $0.68
  • 52 Week High
  • COCP $3.26
  • NEHC $12.29
  • Technical
  • Relative Strength Index (RSI)
  • COCP 51.20
  • NEHC N/A
  • Support Level
  • COCP $1.36
  • NEHC N/A
  • Resistance Level
  • COCP $1.74
  • NEHC N/A
  • Average True Range (ATR)
  • COCP 0.18
  • NEHC 0.00
  • MACD
  • COCP 0.01
  • NEHC 0.00
  • Stochastic Oscillator
  • COCP 50.00
  • NEHC 0.00

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About NEHC NEW ERA HELIUM INC

New Era Helium Inc. is an exploration and production company that sources helium produced in association with the production of natural gas reserves in North America. The Company's primary operations include the exploration, development and production of helium, natural gas, oil and natural gas liquids. The Company owns and operates over 137,000 acres in Southeast New Mexico and has over 1.5 billion cubic feet of proved and probable helium reserves. Its producing oil and gas assets and non-producing acreage are located in Chaves County, New Mexico.

Share on Social Networks: